Advertisement

Ads Placeholder
Loading...

Open Orphan Plc

ORPH.IREURONEXT
Healthcare
Biotechnology
0.14
0.00(0.00%)
U.S. Market opens in 55h 45m

Open Orphan Plc Fundamental Analysis

Open Orphan Plc (ORPH.IR) shows moderate financial fundamentals with a PE ratio of 7.81, profit margin of 16.98%, and ROE of 26.97%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

ROE26.97%
Operating Margin20.50%
PEG Ratio-0.24
Current Ratio1.89

Areas of Concern

No major concerns flagged.
We analyze ORPH.IR's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 74.1/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.

Fundamental Health Score

B
74.1/100

We analyze ORPH.IR's fundamental strength across five key dimensions:

Efficiency Score

Excellent

ORPH.IR demonstrates superior asset utilization.

ROA > 10%
11.98%

Valuation Score

Excellent

ORPH.IR trades at attractive valuation levels.

PE < 25
7.81
PEG Ratio < 2
-0.24

Growth Score

Weak

ORPH.IR faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

ORPH.IR maintains a strong and stable balance sheet.

Debt/Equity < 1
0.29
Current Ratio > 1
1.89

Profitability Score

Moderate

ORPH.IR maintains healthy but balanced margins.

ROE > 15%
26.97%
Net Margin ≥ 15%
16.98%
Positive Free Cash Flow
N/A

Key Financial Metrics

Is ORPH.IR Expensive or Cheap?

P/E Ratio

ORPH.IR trades at 7.81 times earnings. This suggests potential undervaluation.

7.81

PEG Ratio

When adjusting for growth, ORPH.IR's PEG of -0.24 indicates potential undervaluation.

-0.24

Price to Book

The market values Open Orphan Plc at 1.86 times its book value. This may indicate undervaluation.

1.86

EV/EBITDA

Enterprise value stands at 1.76 times EBITDA. This is generally considered low.

1.76

How Well Does ORPH.IR Make Money?

Net Profit Margin

For every $100 in sales, Open Orphan Plc keeps $16.98 as profit after all expenses.

16.98%

Operating Margin

Core operations generate 20.50 in profit for every $100 in revenue, before interest and taxes.

20.50%

ROE

Management delivers $26.97 in profit for every $100 of shareholder equity.

26.97%

ROA

Open Orphan Plc generates $11.98 in profit for every $100 in assets, demonstrating efficient asset deployment.

11.98%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $0.01 in free cash annually.

$0.01

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

7.81

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.24

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.86

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.29

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.89

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.27

vs 25 benchmark

ROA

Return on assets percentage

0.12

vs 25 benchmark

ROCE

Return on capital employed

0.23

vs 25 benchmark

How ORPH.IR Stacks Against Its Sector Peers

MetricORPH.IR ValueSector AveragePerformance
P/E Ratio7.8128.45 Better (Cheaper)
ROE26.97%763.00% Weak
Net Margin16.98%-45265.00% (disorted) Strong
Debt/Equity0.290.34 Neutral
Current Ratio1.892795.60 Neutral
ROA11.98%-16588.00% (disorted) Strong

ORPH.IR outperforms its industry in 3 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Open Orphan Plc's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ